Product
Meningococcal Polysaccharide Tetanus Toxoid Conjugate Vaccine
Aliases
MenACYW Conjugate vaccine, MenACYW conjugate vaccine, MenQuadfi™, Meningococcal Polysaccharide (Serogroups A, C, W, and Y) Tetanus Toxoid Conjugate Vaccine, Meningococcal Polysaccharide (serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine, MenQuadfi
7 clinical trials
4 indications
Indication
Meningococcal InfectionIndication
meningococcal immunizationIndication
Healthy Control ParticipantsIndication
Meningococcal ImmunisationClinical trial
A Phase III, Open-label, Single-center Study to Describe the Immunogenicity and Safety of a Single Dose of MenACYW Conjugate Vaccine in Participants Aged 12 Months and Older in VietnamStatus: Active (not recruiting), Estimated PCD: 2024-04-09
Clinical trial
Safety and Immunogenicity of a Single Dose of MenACYW Conjugate Vaccine at Least 3 Years Following Initial Vaccination With Either Menomune® Vaccine or MenACYW Conjugate Vaccine in Older AdultsStatus: Completed, Estimated PCD: 2020-04-01
Clinical trial
A Phase IIIb, Open-label, Multi-center Study to Evaluate the Immunogenicity and Safety of a Booster Dose and Describe the Immune Persistence of MenACYW Conjugate Vaccine With 5- and/or 10-year Booster Doses in Children and Adolescents Who Had Been Primed With MenACYW Conjugate Vaccine as Toddlers.Status: Active (not recruiting), Estimated PCD: 2023-03-09
Clinical trial
Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Versus Nimenrix®, and When Administered Alone or Concomitantly With 9vHPV and Tdap-IPV Vaccines in Healthy AdolescentsStatus: Completed, Estimated PCD: 2022-05-11
Clinical trial
Safety and Immunogenicity of an Investigational Multicomponent Meningococcal Group B Vaccine in Adults, Adolescents, Toddlers, and InfantsStatus: Active (not recruiting), Estimated PCD: 2026-05-05
Clinical trial
Immunogenicity and Safety of a Single Dose of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Children, Adolescents, and Adults 2 to 55 Years of AgeStatus: Completed, Estimated PCD: 2020-11-07
Clinical trial
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in India and the Republic of South AfricaStatus: Recruiting, Estimated PCD: 2025-09-08